Summit Therapeutics
Manufacturing · Florida, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
601 Brickell Key Dr Ste 1000, Miami, Flo...Phone Number
(650) 382-0001Website
www.smmttx.comRevenue
$33.6 MillionStock Symbol
SMMTIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Summit Therapeutics
Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat Duchenne muscular dystrophy. The company is headquartered in Cambridge, UK.Explore more
Summit Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Summit Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Summit Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Summit Therapeutics
Click to see if Summit Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Summit Therapeutics launches new products
Earning: See what the market has to say on Summit Therapeutics recently announced quarterly report
Summit Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Summit Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Summit Therapeutics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Summit Therapeutics
Compare insights from companies similar to Summit Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Summit Therapeutics
$33.6M
201-500
Public
$1.2B
2003
RM
Rishma MerchantSenior Director and Chief of Staff, Clinical Operations
Company Profile Activity
Activity Insights
Summit Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Summit Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Summit Therapeutics.
Summit Therapeutics financials insights
Gather financial insights about Summit Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$34.2M
2024
Share Placement
$200M
2025
Stock/Share Issuance
$500M
Stock/Share Issuance
$500M
Summit Therapeutics Tech Stack
A closer look at the technologies used by Summit Therapeutics
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Summit Therapeutics News & Media
Summit Therapeutics (SMMT) Published Phase III HARMONi Results In The Lancet Oncology
Summit Therapeutics (NasdaqGM:SMMT) reported that Phase III HARMONi trial results for ivonescimab in EGFR-mutated NSCLC have been published in The Lancet Oncology. The pivotal data show significant clinical benefit for patients in the HARMONi study, according to the published results. The company highlighted that ivonescimab for EGFR-mutated NSCLC is currently under ongoing FDA regulatory review. The growing flow of late stage oncology and immunotherapy data makes it worth looking at...Lowey Dannenberg, P.C. is Investigating Summit Therapeutics Inc. (NASDAQ: SMMT) for Potential Breaches of Fiduciary Duty
Lowey Dannenberg, P.C. is Investigating Summit Therapeutics Inc. (NASDAQ: SMMT)Kuehn Law Encourages Investors of Summit Therapeutics Inc. to Contact Law Firm
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Summit Therapeutics Inc. (NASDAQ: SMMT) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Summit Therapeutics
Sign Up For FreeTo access detailed company insights
Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat Duchenne muscular dystrophy. The company is headquartered in Cambridge, UK.... Read More
